BridgeBio Pharma Inc (BBIO)
23.26
+0.22
(+0.98%)
USD |
NASDAQ |
Nov 21, 16:00
23.26
0.00 (0.00%)
After-Hours: 19:28
BridgeBio Pharma Price: 23.26 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 22.42 | 23.16 | 22.05 | 23.04 | 1.394M |
Nov 19, 2024 | 22.26 | 22.94 | 21.72 | 22.54 | 2.149M |
Nov 18, 2024 | 23.32 | 24.25 | 22.10 | 22.35 | 3.188M |
Nov 15, 2024 | 24.30 | 24.30 | 22.92 | 23.72 | 2.782M |
Nov 14, 2024 | 24.79 | 25.79 | 24.00 | 24.11 | 1.926M |
Nov 13, 2024 | 24.92 | 26.00 | 24.66 | 24.79 | 1.834M |
Nov 12, 2024 | 26.16 | 26.62 | 24.09 | 24.62 | 2.426M |
Nov 11, 2024 | 27.51 | 27.57 | 26.08 | 26.12 | 2.012M |
Nov 08, 2024 | 25.80 | 27.27 | 25.57 | 27.09 | 1.733M |
Nov 07, 2024 | 25.57 | 26.15 | 25.34 | 25.88 | 1.250M |
Nov 06, 2024 | 26.38 | 26.60 | 25.52 | 25.61 | 1.975M |
Nov 05, 2024 | 25.01 | 25.55 | 24.46 | 25.52 | 1.178M |
Nov 04, 2024 | 25.00 | 25.81 | 24.39 | 25.20 | 1.256M |
Nov 01, 2024 | 23.51 | 25.64 | 23.35 | 25.48 | 1.980M |
Oct 31, 2024 | 23.80 | 24.53 | 23.39 | 23.41 | 1.317M |
Oct 30, 2024 | 24.23 | 24.68 | 23.78 | 23.79 | 1.099M |
Oct 29, 2024 | 24.17 | 24.68 | 24.12 | 24.50 | 1.133M |
Oct 28, 2024 | 24.07 | 24.85 | 23.92 | 24.44 | 1.723M |
Oct 25, 2024 | 24.17 | 24.90 | 23.76 | 23.84 | 1.272M |
Oct 24, 2024 | 24.56 | 24.81 | 24.12 | 24.17 | 1.676M |
Oct 23, 2024 | 24.93 | 25.19 | 24.20 | 24.45 | 1.039M |
Oct 22, 2024 | 25.02 | 25.21 | 24.76 | 24.94 | 848458.0 |
Oct 21, 2024 | 25.71 | 26.10 | 25.02 | 25.16 | 1.378M |
Oct 18, 2024 | 26.21 | 26.66 | 25.88 | 26.02 | 1.053M |
Oct 17, 2024 | 26.01 | 26.41 | 25.86 | 26.19 | 998617.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.21
Minimum
May 11 2022
72.35
Maximum
Feb 08 2021
30.03
Average
28.54
Median
Price Benchmarks
Alnylam Pharmaceuticals Inc | 246.88 |
Pfizer Inc | 25.14 |
Vertex Pharmaceuticals Inc | 450.38 |
PTC Therapeutics Inc | 42.92 |
Bristol-Myers Squibb Co | 58.24 |
Price Related Metrics
PS Ratio | 19.48 |
Earnings Yield | -10.36% |
Market Cap | 4.397B |